HK Stock MarketDetailed Quotes
01177 SINO BIOPHARM
Watchlist
2.880
-0.030-1.03%
Trading 09/26 10:07 CST
2.920High2.880Low4.00MVolume
2.900Open2.910Pre Close11.58MTurnover0.02%Turnover Ratio26.42P/E (TTM)54.15BMarket Cap4.94052wk High19.07P/E (Static)18.80BShares2.79052wk Low1.66P/B54.15BFloat Cap11.000Historical High0.06Dividend TTM18.80BShs Float-0.540Historical Low0.120Dividend LFY1.38%Amplitude2.08%Div YieldTTM2.894Avg Price1000Lot Size4.17%Div Yield LFY
SINO BIOPHARM Key Stats
All
YOY

(Q6)2023/06/30 | (FY)2022/12/31 | (Q6)2022/06/30 | (FY)2021/12/31 | (Q6)2021/06/30 | (Q3)2021/03/31 | (FY)2020/12/31 | (Q9)2020/09/30 | (Q6)2020/06/30 | (Q3)2020/03/31 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Inventory | -5.55%2.02B | 20.18%2.33B | 23.42%2.14B | 3.07%1.94B | -3.94%1.73B | 0.36%1.81B | 13.35%1.88B | 10.51%1.76B | 18.62%1.8B | 34.92%1.81B |
Accounts receivable | 43.68%7.11B | 9.90%4.64B | -2.20%4.95B | 44.84%4.22B | 16.87%5.06B | 24.41%3.25B | 7.44%2.91B | -2.22%3.71B | 22.87%4.33B | -15.52%2.61B |
Related party payments receivable | -80.37%79.89M | -5.44%382.74M | 252.58%406.92M | 222.43%404.77M | -20.27%115.41M | -19.41%116.79M | -17.19%125.54M | --148.19M | --144.75M | --144.92M |
Advance deposits and other receivables | 3.08%2.09B | -3.04%1.66B | -68.58%2.03B | -28.48%1.72B | -28.59%6.46B | -40.27%6.27B | -65.25%2.4B | -11.02%6.25B | 34.24%9.05B | 55.72%10.5B |
Cash and equivalents | 49.03%11.58B | 14.17%12.07B | -3.24%7.77B | -6.13%10.57B | -53.03%8.03B | -50.79%7.93B | -5.47%11.26B | 162.43%16.1B | 137.98%17.09B | 160.38%16.12B |
Financial assets at fair value-current assets | -50.18%3.94B | 4.29%4.86B | 227.39%7.91B | 10.41%4.66B | 21.81%2.42B | 36.48%2.4B | 167.52%4.22B | -26.60%2.43B | -31.59%1.98B | -37.26%1.76B |
Special items of current assets | --160.14M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Total current assets | 7.06%26.98B | 10.35%25.93B | 5.81%25.2B | 3.11%23.5B | -30.78%23.81B | -33.86%21.79B | -8.51%22.79B | 39.08%30.4B | 57.33%34.4B | 63.31%32.95B |
Non-current assets | ||||||||||
Property, plant and equipment | 6.80%7.9B | 8.46%7.76B | 4.47%7.39B | 4.13%7.15B | -2.29%7.08B | 0.93%7.06B | 7.70%6.87B | 13.34%7.29B | 19.35%7.24B | 17.61%7B |
Investment property | -2.67%713.65M | 2.14%720.75M | 149.45%733.22M | 128.68%705.63M | -47.60%293.93M | -46.52%303.41M | -45.23%308.56M | 46.40%532.68M | 57.36%560.92M | 61.04%567.33M |
Advance payment | 24.10%651.78M | -15.60%508.26M | -85.74%525.21M | 57.78%602.18M | 592.73%3.68B | 651.77%3.72B | -7.92%381.65M | -68.81%488.95M | -63.26%531.52M | -63.25%495.07M |
Associated company interest | ---- | ---- | 32.05%14.81B | ---- | 1,085.71%11.22B | ---- | --5.05B | 751.11%2.87B | 185.19%946.15M | 207.24%993.2M |
Financial assets at fair value-non-current assets | 33.91%5.5B | 4.10%4.1B | 7.52%4.1B | 2.01%3.94B | --3.82B | --3.87B | --3.87B | ---- | ---- | ---- |
Intangible assets | 75.41%2.13B | 17.65%1.25B | 32.58%1.21B | 15.06%1.06B | -87.68%915.74M | -88.69%848.79M | -30.17%924.71M | -7.33%7.3B | -7.58%7.44B | -7.90%7.5B |
Goodwill | 26.38%812.08M | 2.27%662.61M | -29.08%642.55M | 628.62%647.93M | -93.48%906.03M | -93.59%890.83M | 0.00%88.93M | 0.00%13.9B | 0.00%13.9B | 0.00%13.9B |
Deferred tax assets | 22.83%508.91M | 50.85%505.15M | -40.46%414.31M | -27.73%334.87M | 38.80%695.86M | -21.97%464.06M | -16.86%463.37M | 6.82%503.47M | 4.98%501.34M | 27.13%594.75M |
Special items of non-current assets | 106.73%20.45B | 0.12%22.62B | 161.37%9.89B | 249.50%22.59B | 33.76%3.79B | 286.04%10.2B | 97.44%6.46B | 201.07%2.92B | 188.46%2.83B | 239.78%2.64B |
Total non-current assets | -2.70%38.66B | 2.94%38.13B | 22.67%39.74B | 51.70%37.04B | -4.58%32.39B | -18.79%27.36B | 93.76%24.42B | 12.17%35.8B | 7.41%33.95B | 7.77%33.69B |
Total assets | 1.09%65.64B | 5.82%64.06B | 15.53%64.93B | 28.24%60.54B | -17.76%56.21B | -26.24%49.15B | 25.85%47.21B | 23.11%66.2B | 27.82%68.35B | 29.55%66.64B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Accounts payable | -20.15%2.14B | -3.30%1.64B | 65.14%2.68B | -13.07%1.69B | -42.15%1.62B | -20.47%2.16B | 7.65%1.95B | -0.27%2.36B | 16.67%2.8B | 20.39%2.72B |
Tax payable | 77.81%178.08M | 6.22%107.46M | -60.32%100.15M | 66.66%101.17M | 90.59%252.4M | -57.36%134.82M | -68.03%60.7M | -25.56%239.69M | -2.29%132.43M | 106.48%316.16M |
Amounts payable to associated parties-current liabilities | -92.71%30.95M | 60.98%382.58M | --424.71M | --237.66M | ---- | ---- | ---- | ---- | ---- | ---- |
Other payables and accrued expenses | 58.36%13.98B | 21.18%8.15B | 13.68%8.83B | -8.51%6.73B | 7.03%7.77B | 2.72%6.84B | 35.33%7.35B | 6.18%7B | 6.67%7.26B | 17.01%6.66B |
Bank loans and overdrafts | 157.69%10.48B | -4.65%6.22B | 122.98%4.07B | 319.92%6.52B | 493.25%1.82B | 1,295.46%1.21B | 132.89%1.55B | -61.56%305.87M | -60.93%307.58M | -96.92%86.68M |
Derivative financial instrument-current liabilities | ---- | --146.32M | --117.36M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Financial lease liabilities-current liabilities | -23.58%37.79M | -6.27%60.43M | 133.68%49.45M | 124.65%64.47M | -42.82%21.16M | -35.14%15.72M | 24.35%28.7M | 365.72%37.01M | 132.86%37.01M | --24.24M |
Special items of current liabilities | --15.26M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Total current liabilities | 65.17%26.87B | 31.32%20.15B | 41.62%16.27B | 40.22%15.35B | 9.02%11.49B | 5.69%10.36B | 34.72%10.94B | -1.40%9.94B | 3.87%10.53B | -10.18%9.8B |
Net current assets | -98.75%111.85M | -29.10%5.78B | -27.54%8.93B | -31.16%8.16B | -48.35%12.33B | -50.61%11.43B | -29.42%11.85B | 73.78%20.46B | 103.59%23.87B | 149.86%23.15B |
Total assets less current liabilities | -20.33%38.78B | -2.84%43.91B | 8.83%48.67B | 24.63%45.2B | -22.65%44.72B | -31.75%38.79B | 23.39%36.27B | 28.77%56.26B | 33.43%57.81B | 40.25%56.84B |
Non-current liabilities | ||||||||||
Long-term bank loan | -84.10%685.63M | 851.73%3.93B | -31.25%4.31B | -94.03%413.34M | -22.78%6.27B | -13.70%7.01B | -12.21%6.92B | 216.96%7.87B | 239.42%8.12B | 1,400.56%8.13B |
Financial lease liabilities-non-current liabilities | -7.56%329.25M | 1.35%324.26M | 22.25%356.18M | 20.80%319.95M | 603.85%291.36M | 537.06%263.71M | 541.78%264.86M | -41.41%41.4M | -41.41%41.4M | --41.4M |
Deferred tax liability | -39.21%623.45M | -5.65%831.79M | 32.59%1.03B | 413.59%881.59M | -50.96%773.5M | -78.96%326.03M | -59.45%171.65M | -7.53%1.46B | -3.55%1.58B | -4.63%1.55B |
Deferred income-non-current liabilities | -24.33%525.68M | 11.06%749.07M | 19.80%694.74M | 10.89%674.45M | 85.32%579.92M | 78.32%578.16M | 26.54%608.2M | -5.43%403.57M | -25.12%312.93M | -18.55%324.23M |
Convertible notes and bonds | -99.50%16.46M | ---- | -41.80%3.31B | -15.79%4.95B | -8.97%5.69B | 0.81%5.76B | --5.88B | --6.03B | --6.26B | --5.71B |
Special items of non-current liabilities | -38.30%136.2M | -42.51%131.08M | --220.74M | --227.98M | ---- | ---- | ---- | ---- | ---- | ---- |
Total non-current liabilities | -76.66%2.32B | -20.07%5.97B | -27.09%9.92B | -46.06%7.47B | -16.54%13.61B | -11.51%13.94B | 56.82%13.85B | 246.87%15.8B | 261.09%16.31B | 514.45%15.76B |
Total liabilities | 11.43%29.18B | 14.49%26.12B | 4.35%26.19B | -7.97%22.81B | -6.51%25.1B | -4.92%24.3B | 46.23%24.79B | 75.83%25.74B | 83.12%26.85B | 89.65%25.56B |
Total assets less total liabilities | -5.90%36.46B | 0.57%37.94B | 24.54%38.74B | 68.29%37.73B | -25.04%31.11B | -39.51%24.85B | 9.04%22.42B | 3.39%40.46B | 6.93%41.5B | 8.22%41.08B |
Total equity and non-current liabilities | -20.33%38.78B | -2.84%43.91B | 8.83%48.67B | 24.63%45.2B | -22.65%44.72B | -31.75%38.79B | 23.39%36.27B | 28.77%56.26B | 33.43%57.81B | 40.25%56.84B |
Equity | ||||||||||
Share capital | -0.08%414.62M | -0.13%414.9M | -0.23%414.94M | -0.11%415.44M | 49.44%415.9M | 49.43%415.9M | 49.36%415.9M | 49.45%416.14M | -0.05%278.3M | -0.05%278.32M |
Reserve | 0.08%31.2B | 0.65%30.76B | 26.59%31.18B | 81.92%30.57B | -22.18%24.63B | -41.21%18.72B | 11.39%16.8B | 3.02%31.67B | 5.24%31.65B | 6.81%31.84B |
Legal reserve | 0.08%31.2B | 0.65%30.76B | 26.59%31.18B | 81.92%30.57B | -22.18%24.63B | -41.21%18.72B | 11.39%16.8B | 3.02%31.67B | 5.24%31.65B | 6.81%31.84B |
Special items of shareholders' rights and interests | -18.00%-1.63B | -107.80%-1.43B | -193.35%-1.38B | -46.69%-689.35M | -13.83%-469.94M | -13.83%-469.94M | -13.83%-469.94M | 6.90%-412.84M | 3.42%-412.84M | 0.71%-412.84M |
Shareholders' Equity | -0.74%29.99B | -1.80%29.75B | 22.94%30.21B | 80.87%30.29B | -22.02%24.58B | -41.13%18.67B | 12.03%16.75B | 3.59%31.67B | 5.31%31.51B | 6.85%31.71B |
Non-controlling interest | -24.16%6.47B | 10.20%8.2B | 30.57%8.53B | 31.12%7.44B | -34.59%6.53B | -34.03%6.19B | 1.08%5.67B | 2.68%8.79B | 12.40%9.99B | 13.12%9.38B |
Total equity | -5.90%36.46B | 0.57%37.94B | 24.54%38.74B | 68.29%37.73B | -25.04%31.11B | -39.51%24.85B | 9.04%22.42B | 3.39%40.46B | 6.93%41.5B | 8.22%41.08B |
Total equity and total liabilities | 1.09%65.64B | 5.82%64.06B | 15.53%64.93B | 28.24%60.54B | -17.76%56.21B | -26.24%49.15B | 25.85%47.21B | 23.11%66.2B | 27.82%68.35B | 29.55%66.64B |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | -- | Unqualified Opinion | -- | -- | -- |
Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | -- | Ernst & Young | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Paper Trade
Start
Symbol
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--